Article
A differentiated and durable allogeneic strategy applicable to cell therapies
2025-04-01
Abstract excerpt
Autologous T cell therapies have shown profound clinical responses; however, their widespread use has been limited primarily due to their individualized manufacturing requirements. To develop a persistent "off-the-shelf" allogeneic (Allo) approach, a multiplex Nme2Cas9-based cytosine base editor was deployed to knockout select HLA Class I and II alleles ( HLA-A , HLA-B , and the class II transactivator ( CIITA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ef44d36a-bf9a-5c40-8a9f-fe164269603c
- DOI
- 10.1101/2025.03.27.645807
